Abstract

Children under the age of five are most likely to contract meningitis, with young people between 15 to 19 experiencing a lower peak in frequency. The incidence of sickness brought on by these strains has decreased since the Haemophilus influenzae type b (Hib) and group C meningococcus vaccines were added to the pediatric immunization schedule decrease in pathogens all ages with acute bacterial meningitis. Objectives- To examine the most recent research on the efficiency and safety of using corticosteroids to treat young patients with acute bacterial meningitis. Methods- Randomised controlled trials (RCTs) of corticosteroids for acute bacterial meningitis was done. We searched CENTRAL, MEDLINE, Embase, Web of science,CINAHL and LILACS so among literature four evidence based meta-analysis was selected in which 25 studies were quality based studies, We scored RCTs for methodological quality. We collected outcomes and adverse effects. We performed subgroup analyses for children and adults, causative organisms, low-income versus high-income countries, time of steroid administration and study quality.

Description